Target intelligence / Profile preview

Methionine-R-sulfoxide reductase B2, mitochondrial (MSRB2)

Target
MSRB2
Molecular classification
Enzyme, Oxidoreductase, Zinc-containing protein
01

Overview

Methionine-R-sulfoxide reductase B2, mitochondrial (MSRB2), is a zinc-containing oxidoreductase enzyme encoded by the MSRB2 gene in humans and localized to mitochondria[3][5][7][1]. MSRB2 specifically reduces methionine (R)-sulfoxide residues in proteins back to methionine, playing a critical role in the cellular defense against oxidative stress by repairing oxidatively damaged methionine. Structurally, MSRB2 is a globular protein with eight anti-parallel β-strands and three N-terminal α-helices, and a tetrahedral zinc ion stabilizing its top portion[1][2]. Unlike MsrB1, which contains a resolving selenocysteine, MSRB2 uses cysteine as its catalytic residue and does not contain a resolving Cys, leading to different catalytic mechanisms between the two enzymes[1]. MSRB2 contributes to mitochondrial integrity and cell survival by decreasing intracellular reactive oxygen species and maintaining protein function after oxidative insults[3]. It is highly expressed in muscle tissues and less so in the brain[5]. Mutations in MSRB2 are associated with rare congenital disorders and may contribute to broader pathologies via its role in redox homeostasis[3][5].

Other names
Methionine sulfoxide reductase B2MSRB2CBS-1MsrB2PILBCGI-131CBS1
02

Mechanism of action

Reduces methionine (R)-sulfoxide back to methionine, thereby repairing oxidative damage to proteins and decreasing ROS build-up

03

Biological functions

Protein repair (repair of oxidatively damaged methionine residues)Redox regulation (antioxidant defense via reduction of methionine (R)-sulfoxide)Maintenance of mitochondrial integrityCell survival under oxidative stress
04

Disease associations

Neu-Laxova Syndrome 2Batten-Turner Congenital MyopathyPotential roles in neurodegeneration and aging (due to protein repair function and ROS regulation)

Beyond the preview

Go deeper on Methionine-R-sulfoxide reductase B2, mitochondrial (MSRB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methionine-R-sulfoxide reductase B2, mitochondrial (MSRB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call